vs
Amphastar Pharmaceuticals, Inc.（AMPH）与HAVERTY FURNITURE COMPANIES INC（HVT）财务数据对比。点击上方公司名可切换其他公司
HAVERTY FURNITURE COMPANIES INC的季度营收约是Amphastar Pharmaceuticals, Inc.的1.1倍（$201.9M vs $183.1M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs 4.2%，领先9.1%），HAVERTY FURNITURE COMPANIES INC同比增速更快（9.5% vs -1.8%），Amphastar Pharmaceuticals, Inc.自由现金流更多（$24.6M vs $3.0M），过去两年HAVERTY FURNITURE COMPANIES INC的营收复合增速更高（4.8% vs 3.2%）
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
该企业原名为国际鞋业公司，1911年由两家鞋企合并成立于美国密苏里州克莱顿，后开展多元化业务并逐步退出制鞋领域，最终更名为家具品牌国际，是美国家居行业知名企业，曾拥有布罗伊希尔等多个知名家具品牌。
AMPH vs HVT — 直观对比
营收规模更大
HVT
是对方的1.1倍
$183.1M
营收增速更快
HVT
高出11.4%
-1.8%
净利率更高
AMPH
高出9.1%
4.2%
自由现金流更多
AMPH
多$21.6M
$3.0M
两年增速更快
HVT
近两年复合增速
3.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.1M | $201.9M |
| 净利润 | $24.4M | $8.5M |
| 毛利率 | 46.8% | 60.4% |
| 营业利润率 | 19.4% | 5.3% |
| 净利率 | 13.3% | 4.2% |
| 营收同比 | -1.8% | 9.5% |
| 净利润同比 | -35.7% | 4.1% |
| 每股收益（稀释后） | $0.51 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPHHVT
| Q4 25 | $183.1M | $201.9M | ||
| Q3 25 | $191.8M | $194.5M | ||
| Q2 25 | $174.4M | $181.0M | ||
| Q1 25 | $170.5M | $181.6M | ||
| Q4 24 | $186.5M | $184.4M | ||
| Q3 24 | $191.2M | $175.9M | ||
| Q2 24 | $182.4M | $178.6M | ||
| Q1 24 | $171.8M | $184.0M |
净利润AMPHHVT
| Q4 25 | $24.4M | $8.5M | ||
| Q3 25 | $17.4M | $4.7M | ||
| Q2 25 | $31.0M | $2.7M | ||
| Q1 25 | $25.3M | $3.8M | ||
| Q4 24 | $38.0M | $8.2M | ||
| Q3 24 | $40.4M | $4.9M | ||
| Q2 24 | $37.9M | $4.4M | ||
| Q1 24 | $43.2M | $2.4M |
毛利率AMPHHVT
| Q4 25 | 46.8% | 60.4% | ||
| Q3 25 | 51.4% | 60.3% | ||
| Q2 25 | 49.6% | 60.8% | ||
| Q1 25 | 50.0% | 61.2% | ||
| Q4 24 | 46.5% | 61.9% | ||
| Q3 24 | 53.3% | 60.2% | ||
| Q2 24 | 52.2% | 60.4% | ||
| Q1 24 | 52.4% | 60.3% |
营业利润率AMPHHVT
| Q4 25 | 19.4% | 5.3% | ||
| Q3 25 | 13.2% | 3.3% | ||
| Q2 25 | 24.2% | 2.4% | ||
| Q1 25 | 21.9% | 2.9% | ||
| Q4 24 | 24.2% | 5.2% | ||
| Q3 24 | 29.8% | 3.9% | ||
| Q2 24 | 30.3% | 3.6% | ||
| Q1 24 | 27.9% | 1.7% |
净利率AMPHHVT
| Q4 25 | 13.3% | 4.2% | ||
| Q3 25 | 9.0% | 2.4% | ||
| Q2 25 | 17.8% | 1.5% | ||
| Q1 25 | 14.8% | 2.1% | ||
| Q4 24 | 20.4% | 4.4% | ||
| Q3 24 | 21.1% | 2.8% | ||
| Q2 24 | 20.8% | 2.5% | ||
| Q1 24 | 25.1% | 1.3% |
每股收益（稀释后）AMPHHVT
| Q4 25 | $0.51 | — | ||
| Q3 25 | $0.37 | — | ||
| Q2 25 | $0.64 | — | ||
| Q1 25 | $0.51 | — | ||
| Q4 24 | $0.74 | — | ||
| Q3 24 | $0.78 | — | ||
| Q2 24 | $0.73 | — | ||
| Q1 24 | $0.81 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.8M | $125.3M |
| 总债务越低越好 | $608.7M | — |
| 股东权益账面价值 | $788.8M | $307.9M |
| 总资产 | $1.6B | $649.1M |
| 负债/权益比越低杠杆越低 | 0.77× | — |
8季度趋势，按日历期对齐
现金及短期投资AMPHHVT
| Q4 25 | $282.8M | $125.3M | ||
| Q3 25 | $276.2M | $130.5M | ||
| Q2 25 | $231.8M | $107.4M | ||
| Q1 25 | $236.9M | $111.9M | ||
| Q4 24 | $221.6M | $120.0M | ||
| Q3 24 | $250.5M | $121.2M | ||
| Q2 24 | $217.8M | $109.9M | ||
| Q1 24 | $289.6M | $111.8M |
总债务AMPHHVT
| Q4 25 | $608.7M | — | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | — | ||
| Q3 24 | $596.4M | — | ||
| Q2 24 | $586.9M | — | ||
| Q1 24 | $594.0M | — |
股东权益AMPHHVT
| Q4 25 | $788.8M | $307.9M | ||
| Q3 25 | $776.7M | $306.0M | ||
| Q2 25 | $757.5M | $304.9M | ||
| Q1 25 | $751.3M | $305.4M | ||
| Q4 24 | $732.3M | $307.6M | ||
| Q3 24 | $727.7M | $307.8M | ||
| Q2 24 | $713.3M | $307.1M | ||
| Q1 24 | $672.4M | $306.7M |
总资产AMPHHVT
| Q4 25 | $1.6B | $649.1M | ||
| Q3 25 | $1.7B | $651.7M | ||
| Q2 25 | $1.6B | $642.7M | ||
| Q1 25 | $1.6B | $642.7M | ||
| Q4 24 | $1.6B | $648.7M | ||
| Q3 24 | $1.5B | $659.3M | ||
| Q2 24 | $1.5B | $642.1M | ||
| Q1 24 | $1.6B | $640.5M |
负债/权益比AMPHHVT
| Q4 25 | 0.77× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | — | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $7.4M |
| 自由现金流经营现金流 - 资本支出 | $24.6M | $3.0M |
| 自由现金流率自由现金流/营收 | 13.4% | 1.5% |
| 资本支出强度资本支出/营收 | 4.5% | 2.2% |
| 现金转化率经营现金流/净利润 | 1.35× | 0.86× |
| 过去12个月自由现金流最近4个季度 | $121.2M | $33.0M |
8季度趋势，按日历期对齐
经营现金流AMPHHVT
| Q4 25 | $32.9M | $7.4M | ||
| Q3 25 | $52.6M | $31.9M | ||
| Q2 25 | $35.6M | $7.2M | ||
| Q1 25 | $35.1M | $6.2M | ||
| Q4 24 | $29.0M | $16.9M | ||
| Q3 24 | $60.0M | $24.4M | ||
| Q2 24 | $69.1M | $14.4M | ||
| Q1 24 | $55.3M | $3.1M |
自由现金流AMPHHVT
| Q4 25 | $24.6M | $3.0M | ||
| Q3 25 | $47.2M | $28.3M | ||
| Q2 25 | $25.0M | $1.6M | ||
| Q1 25 | $24.4M | $27.0K | ||
| Q4 24 | $16.6M | $9.1M | ||
| Q3 24 | $46.2M | $16.1M | ||
| Q2 24 | $63.1M | $4.9M | ||
| Q1 24 | $46.5M | $-3.3M |
自由现金流率AMPHHVT
| Q4 25 | 13.4% | 1.5% | ||
| Q3 25 | 24.6% | 14.6% | ||
| Q2 25 | 14.3% | 0.9% | ||
| Q1 25 | 14.3% | 0.0% | ||
| Q4 24 | 8.9% | 4.9% | ||
| Q3 24 | 24.1% | 9.2% | ||
| Q2 24 | 34.6% | 2.7% | ||
| Q1 24 | 27.1% | -1.8% |
资本支出强度AMPHHVT
| Q4 25 | 4.5% | 2.2% | ||
| Q3 25 | 2.8% | 1.8% | ||
| Q2 25 | 6.1% | 3.1% | ||
| Q1 25 | 6.3% | 3.4% | ||
| Q4 24 | 6.7% | 4.2% | ||
| Q3 24 | 7.2% | 4.7% | ||
| Q2 24 | 3.3% | 5.3% | ||
| Q1 24 | 5.1% | 3.5% |
现金转化率AMPHHVT
| Q4 25 | 1.35× | 0.86× | ||
| Q3 25 | 3.03× | 6.75× | ||
| Q2 25 | 1.15× | 2.69× | ||
| Q1 25 | 1.39× | 1.63× | ||
| Q4 24 | 0.76× | 2.06× | ||
| Q3 24 | 1.48× | 4.96× | ||
| Q2 24 | 1.82× | 3.25× | ||
| Q1 24 | 1.28× | 1.31× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
HVT
| Upholstery | $91.0M | 45% |
| Bedroom Furniture | $29.2M | 14% |
| Accessories And Other | $28.4M | 14% |
| Dining Room Furniture | $22.8M | 11% |
| Mattresses | $16.1M | 8% |
| Occasional | $14.4M | 7% |
